Pulse Biosciences, Inc. PLSE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $68.32M-15.4% | $80.74M-15.2% | $95.21M-10.5% | $106.35M-10.8% | $119.28M+1.1% | ||
| —— | —— | —— | —— | —— | ||
| $450K+64.2% | $274K+98.6% | $138K+70.4% | $81K+170% | $30K— | ||
| $71.13M-14.7% | $83.42M-14.1% | $97.16M-10.2% | $108.16M-10.5% | $120.91M+1.2% | ||
| $1.02M-3.3% | $1.05M-0.4% | $1.06M-4.9% | $1.11M+4.4% | $1.06M-8.4% | ||
| $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | ||
| $408K-29.0% | $575K-22.4% | $741K-18.3% | $907K-13.9% | $1.05M-13.6% | ||
| $81.62M-13.7% | $94.54M-13.1% | $108.77M-9.6% | $120.25M-9.8% | $133.38M+0.7% | ||
| $2.76M-0.6% | $2.78M-6.7% | $2.98M+8.6% | $2.74M+15.7% | $2.37M+41.7% | ||
| $9.8M+23.6% | $7.92M-18.3% | $9.7M+8.0% | $8.98M+15.7% | $7.76M-22.8% | ||
| $15.32M+10.4% | $13.88M-13.6% | $16.07M+1.9% | $15.76M+5.6% | $14.93M-15.2% | ||
| $68K0.0% | $68K0.0% | $68K+1.5% | $67K0.0% | $67K+1.5% | ||
| -$481.86M-4.0% | -$463.28M-3.9% | -$445.85M-4.5% | -$426.46M-4.7% | -$407.3M-4.3% | ||
| $66.3M-17.8% | $80.66M-13.0% | $92.69M-11.3% | $104.49M-11.8% | $118.45M+3.1% | ||
| $81.62M-13.7% | $94.54M-13.1% | $108.77M-9.6% | $120.25M-9.8% | $133.38M+0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Pulse Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 7.26 — current assets exceed current liabilities.
- Where does Pulse Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.